Matthew Gall - 16 Jun 2021 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Financial Officer
Signature
/s/ Michel Detheux, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
16 Jun 2021
Net transactions value
+$130,446
Form type
4
Filing time
16 Jun 2021, 18:46:44 UTC
Next filing
25 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Purchase $130,446 +5,000 $26.09 5,000 16 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.84 to $26.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.